Sleep disorders (combined)

SLEEP

No definition available.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

49878

diagram downward connector
SLEEP

Control definitions

Control exclude F5_BEHAVE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 49878 21581 28297
Unadjusted prevalence (%) 12.11 9.37 15.57
Mean age at first event (years) 54.59 53.95 55.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 1.67 [1.42, 1.95] 2.8e-10 3120
15 years 0.01 1.19 [1.03, 1.37] 1.7e-2 1315
5 years 0.00 2.39 [2.11, 2.71] 6.3e-42 831
1 year 0.00 4.53 [3.85, 5.32] 1.8e-75 304

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: SLEEP – Sleep disorders (combined)
GWS hits: 21

Survival analyses between endpoints

↥

Plot

before Sleep disorders (combined)
after Sleep disorders (combined)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Sleep disorders (combined)

↥

Endpoint not on priority list, no data to show.